SDGR · Company research

Schrodinger, Inc. Common Stock (SDGR): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

21records availableHealthcare

Stock News & Events data

Database-backed records only

21 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Schrodinger Inc. Stock Grades | SDGR - Barron'sSchrodinger Inc. Stock Grades | SDGR Barron'sView source ↗Barron'sOct 19, 2026neutral00.6
$SDGR stock is down 12% today. Here's what we see in our data. - Quiver Quantitative$SDGR stock is down 12% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeOct 16, 2026neutral00.6
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo FinanceSchrodinger, Inc. (SDGR) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Up to 40% of lithium ions in battery fluid cluster. This could help guide battery design. - Stock TitanUp to 40% of lithium ions in battery fluid cluster. This could help guide battery design. Stock TitanView source ↗Stock TitanOct 14, 2026neutral00.6
Schrödinger (SDGR) Stock Fair Value Edges Higher As Analyst Views Split On AI Growth - Yahoo FinanceSchrödinger (SDGR) Stock Fair Value Edges Higher As Analyst Views Split On AI Growth Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Schrodinger Inc (SDGR) Shares Fall 5.0% -- What GF Score of 72 T - GuruFocusSchrodinger Inc (SDGR) Shares Fall 5.0% -- What GF Score of 72 T GuruFocusView source ↗GuruFocusOct 12, 2026neutral00.6
Schrodinger Inc. Stock Grades | SDGR - Barron'sSchrodinger Inc. Stock Grades | SDGR Barron'sView source ↗Barron'sOct 12, 2026neutral00.6
Schrodinger Inc (SDGR) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 72/100 - GuruFocusSchrodinger Inc (SDGR) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 72/100 GuruFocusView source ↗GuruFocusOct 10, 2026neutral00.6
Schrodinger Stock Price Forecast. Should You Buy SDGR? - StockInvest.usSchrodinger Stock Price Forecast. Should You Buy SDGR? StockInvest.usView source ↗StockInvest.usOct 9, 2026neutral00.6
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo FinanceSchrodinger, Inc. (SDGR) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 7, 2026neutral00.6
Schrödinger Shares Slide 11.6% as Rally Reverses Without a Fresh Catalyst - Quiver QuantitativeSchrödinger Shares Slide 11.6% as Rally Reverses Without a Fresh Catalyst Quiver QuantitativeView source ↗Quiver QuantitativeOct 6, 2026neutral00.6
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?Schrodinger shares surged 7.6% to close at $32.6, driven by investor optimism following the announcement of Tectora, a new biotech company co-founded by Schrodinger, NEA, and RA Capital Management focused on immunology and inflammation therapies. The company secured $55 million in Series A funding. Despite expected quarterly losses of $0.66 per share and a 15.3% revenue decline, consensus EPS estimates have been revised 72.2% higher over the past 30 days, suggesting potential for continued strength. SDGR carries a Zacks Rank #3 (Hold).View source ↗Zacks Investment ResearchOct 6, 2026bullish0.51
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?Schrodinger shares surged 7.6% to close at $32.6, driven by investor optimism following the announcement of Tectora, a new biotech company co-founded by Schrodinger, NEA, and RA Capital Management focused on immunology and inflammation therapies. The company secured $55 million in Series A funding. Despite expected quarterly losses of $0.66 per share and a 15.3% revenue decline, consensus EPS estimates have been revised 72.2% higher over the past 30 days, suggesting potential for continued strength. SDGR carries a Zacks Rank #3 (Hold).View source ↗Zacks Investment ResearchOct 6, 2026bullish0.51
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? - Yahoo FinanceSchrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? Yahoo FinanceView source ↗Yahoo FinanceOct 6, 2026neutral00.6
Global Drug Discovery AI Tools Market - Strategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth OpportunitiesA comprehensive market research report examines the growing role of AI tools in drug discovery, covering applications in target identification, molecular design, and preclinical testing. The market is shifting from isolated computational experiments toward integrated workflows combining data systems and laboratory validation. Success depends on data quality, model interpretability, regulatory compliance, and multidisciplinary expertise across biology, chemistry, and data science.View source ↗GlobeNewswire Inc.Oct 5, 2026bullish11
SDGR Stock: Schrödinger Hopes Its AI Agent Can Transform Drug Discovery - CMC MarketsSDGR Stock: Schrödinger Hopes Its AI Agent Can Transform Drug Discovery CMC MarketsView source ↗CMC MarketsOct 1, 2026neutral00.6
Schrödinger (SDGR) Stock May Be Below Fair Value On Tectora Deal - Simply Wall StreetSchrödinger (SDGR) Stock May Be Below Fair Value On Tectora Deal Simply Wall StreetView source ↗Simply Wall StreetSep 23, 2026neutral00.6
Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock TitanOptions at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider Stock TitanView source ↗Stock TitanSep 21, 2026neutral00.6
Schrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR) - Seeking AlphaSchrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR) Seeking AlphaView source ↗Seeking AlphaAug 21, 2026neutral00.6
Schrödinger (SDGR) Stock Rallies On Profit Turn But Durability Questions Remain - Simply Wall StreetSchrödinger (SDGR) Stock Rallies On Profit Turn But Durability Questions Remain Simply Wall StreetView source ↗Simply Wall StreetAug 6, 2026neutral00.6
BMS to Deploy Schrödinger’s AI Co-Scientist for Drug Discovery - Stock TitanBMS to Deploy Schrödinger’s AI Co-Scientist for Drug Discovery Stock TitanView source ↗Stock TitanAug 5, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.